Vor Biopharma Inc (VOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VOR | AZN | AMGN | GILD | VRTX |
| Company | Vor Biopharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 12.00 | 89.40 | 317.30 | 122.86 | 444.81 |
| High | 14.13 | 89.96 | 319.46 | 123.63 | 456.00 |
| Low | 11.77 | 89.28 | 315.19 | 119.80 | 444.81 |
| Latest | 12.58 | 89.74 | 316.62 | 119.90 | 450.79 |
| Change | +0.45 | -0.55 | -0.76 | -3.31 | +4.86 |
| % Change | +3.71% | -0.61% | -0.24% | -2.69% | +1.09% |
| Volume | 2,944,851 | 3,464,314 | 1,135,504 | 3,538,450 | 963,889 |
| 20-Day Average Volume | 3,042,241 | 5,588,341 | 2,801,651 | 6,880,928 | 1,355,457 |
| Previous Close | 12.13 | 90.29 | 317.38 | 123.21 | 445.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.92 | 90.60 | 333.99 | 124.21 | 437.62 |
| 20-Day Raw Stochastic | 81.85% | 28.25% | 12.96% | 14.26% | 73.08% |
| 20-Day Relative Strength | 44.00 | 55.59 | 47.21 | 46.93 | 59.18 |
| Weighted Alpha | -69.07 | +37.97 | +17.05 | +27.44 | +1.53 |
| Today's Opinion | 72% Sell | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 72% Sell | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 56% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +55.81% since 12/05/25 | -0.31% since 12/05/25 | -3.97% since 12/05/25 | -0.85% since 12/05/25 | -0.84% since 12/05/25 |
| Low | 7.99 on 12/08/25 | 89.29 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 14.13 on 12/12/25 | 91.66 on 12/10/25 | 329.67 on 12/08/25 | 123.74 on 12/11/25 | 457.17 on 12/08/25 |
| 1-Month | |||||
| %Chg | +26.69% since 11/12/25 | +2.53% since 11/12/25 | -5.80% since 11/12/25 | -2.60% since 11/12/25 | +4.02% since 11/12/25 |
| Low | 6.50 on 11/20/25 | 87.62 on 11/13/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 14.13 on 12/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -63.38% since 09/12/25 | +13.00% since 09/12/25 | +14.62% since 09/12/25 | +4.92% since 09/12/25 | +14.48% since 09/12/25 |
| Low | 6.50 on 11/20/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 49.95 on 09/30/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +203.46% since 06/12/25 | +19.87% since 06/12/25 | +6.56% since 06/12/25 | +7.26% since 06/12/25 | -1.83% since 06/12/25 |
| Low | 3.63 on 06/13/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 65.80 on 07/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 126,285 | 280,027,776 | 170,903,104 | 152,864,192 | 113,140,912 |
| Shares Outstanding, K | 10,411 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -116,914,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -812,684,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 2.08 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.33 on 11/13/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/19/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.02 | 14.42 | 14.82 | 29.04 |